PHARMACEUTICAL RESEARCH

期刊名
PHARMACEUTICAL RESEARCH

PHARM RES-DORDR

ISSN / eISSN
0724-8741 / 1573-904X
目标和范围
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to:

-(pre)formulation engineering and processing-
computational biopharmaceutics-
drug delivery and targeting-
molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)-
pharmacokinetics, pharmacodynamics and pharmacogenetics.
Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
研究方向

化学:综合

药学

CiteScore
6.60 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Pharmacology (medical) Q1 #65/272
Medicine - Organic Chemistry Q2 #58/211
Medicine - Pharmaceutical Science Q2 #51/183
Medicine - Pharmacology Q2 #103/313
Medicine - Biotechnology Q2 #107/311
Medicine - Molecular Medicine Q2 #76/178
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
CHEMISTRY, MULTIDISCIPLINARY Q2
PHARMACOLOGY & PHARMACY Q2
H-index
191
出版国家或地区
GERMANY
出版商
Springer US
出版周期
Monthly
出版年份
1984
年文章数
182
Open Access
NO
通讯方式
SPRINGER/PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, USA, NY, 10013
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Continuing from above, the submitted content is related to pharmacokinetics. I personally do not consider it to be novel, but there is a substantial amount of content. Both reviewers asked good questions, some of which were indeed difficult to answer. When revising, I maintained a sincere attitude and did not provide any unconvincing answers.
2021-10-16
6.28 submitted
7.15 under review
8.09 major revision
9.05 revision submitted
9.10 under review
10.08 minor revision
10.09 revision submitted
10.15 accept
2021-10-16

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now